Defibrotide Low-Dose Continuous Infusion from Day +1 Until Day +21 after Allogeneic Stem Cell Transplantation as Prophylaxis of Veno-Occlusive Disease (VOD) of the Liver. A Single Centre Experience.
Alessandro Bonini, Luigi Gugliotta(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Alessia Tieghi(Azienda Sanitaria Unità Locale di Reggio Emilia), Paolo Avanzini(Santa Maria Nuova Hospital), Fiorella Ilariucci(Azienda Sanitaria Unità Locale di Reggio Emilia), Barbara Gamberi(University of Modena and Reggio Emilia), Annalisa Immovilli(Azienda Ospedaliera S.Maria), Francesco Merli(Azienda Sanitaria Unità Locale di Reggio Emilia), Luciano Masini(Casa di Cura Villa Garda), Isabel Alvarez(Azienda Ospedaliera S.Maria), Annalisa Pilia(Azienda Ospedaliera S.Maria)
Cited by 3
Related Papers
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study
|Journal of Clinical Oncology|2007|374